Product Information
ETRAVIRINE 200 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $11.4115 per EA under NDC 69315028606. Its NADAC has been published 203 times since Aug 10, 2022.
Strength
200 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315028606
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETRAVIRINEApproval Type
Generic (ANDA)
FDA Application
ANDA215402On Market Since
6/5/2022
Pharmacological Classes
Price Statistics
The NADAC for ETRAVIRINE 200 MG TABLET has been published 203 times since Aug 10, 2022, and over the history we have for it it has declined 35.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4115 per EA |
|---|---|
| All-time high | $17.7091 (Mar 15, 2023) |
| All-time low | $11.2785 (May 20, 2026) |
| 52-week high | $12.8167 |
| 52-week low | $11.2785 |
| Median price | $13.2688 |
| Average price | $14.1382 |
| Largest weekly change | +13.4% (Oct 23, 2024) |
| Weeks tracked | 203 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ETRAVIRINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ETRAVIRINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETRAVIRINE 200 MG TABLET, manufactured by Leading Pharma, LLC, is $11.4115 per EA (NDC 69315028606), effective Jun 24, 2026.
How has the price of ETRAVIRINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETRAVIRINE 200 MG TABLET has declined 35.6%. It has been tracked across 203 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for ETRAVIRINE 200 MG TABLET?
Since Aug 10, 2022, the NADAC for ETRAVIRINE 200 MG TABLET has ranged from a low of $11.2785 (May 20, 2026) to a high of $17.7091 (Mar 15, 2023), with a median of $13.2688 per EA.
Are there cheaper alternatives to ETRAVIRINE 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ETRAVIRINE 200 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ETRAVIRINE 200 MG TABLET?
ETRAVIRINE 200 MG TABLET (NDC 69315028606) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification